A promoterless retroviral vector indicates that there are sequences in U3 required for 3' RNA processing.
about
Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virusMutational analysis of the envelope protein of spleen necrosis virusSelf-inactivating lentivirus vector for safe and efficient in vivo gene delivery.Utilization of nonviral sequences for minus-strand DNA transfer and gene reconstitution during retroviral replication.Effects of homology length in the repeat region on minus-strand DNA transfer and retroviral replication.Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector.Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector.cis-Acting elements important for retroviral RNA packaging specificity.Lentivirus and foamy virus vectors: novel gene therapy tools.Upstream and downstream cis-acting elements for cleavage at the L4 polyadenylation site of adenovirus-2.Retroviruses as genetic tools to isolate transcriptionally active chromosomal regions.Transient expression analysis of the reticuloendotheliosis virus long terminal repeat elementE- vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy.The recombination rate is not increased when retroviral RNA is missing an encapsidation sequencePsi- vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors.Stable gammaretroviral vector expression during embryonic stem cell-derived in vitro hematopoietic development.Retrovirus promoter-trap vector to induce lacZ gene fusions in mammalian cells.Activator-dependent and activator-independent defective recombinant retroviruses from bovine leukemia virus.Unusually high frequency of reconstitution of long terminal repeats in U3-minus retrovirus vectors by DNA recombination or gene conversion.Improvement of avian leukosis virus (ALV)-based retrovirus vectors by using different cis-acting sequences from ALVscDNA genes formed after infection with retroviral vector particles lack the hallmarks of natural processed pseudogenes.Retroviral vector system for the study of cDNA gene formation.The U3 region is not necessary for 3' end formation of spleen necrosis virus RNA.Presence of a retroviral encapsidation sequence in nonretroviral RNA increases the efficiency of formation of cDNA genes.New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors.Identification of cellular promoters by using a retrovirus promoter trap.Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes.Lack of competition results in efficient packaging of heterologous murine retroviral RNAs and reticuloendotheliosis virus encapsidation-minus RNAs by the reticuloendotheliosis virus helper cell lineNonreciprocal pseudotyping: murine leukemia virus proteins cannot efficiently package spleen necrosis virus-based vector RNA.Endothelial cell-specific transcriptional targeting from a hybrid long terminal repeat retrovirus vector containing human prepro-endothelin-1 promoter sequencesEvidence for retroviral intramolecular recombinations.RNAs from genetically distinct retroviruses can copackage and exchange genetic information in vivo.A conditional self-inactivating retrovirus vector that uses a tetracycline-responsive expression system.Improved self-inactivating retroviral vectors derived from spleen necrosis virus.The LTR, v-src, LTR provirus generated in the mammalian genome by src mRNA reverse transcription and integration.Regulation of polyadenylation in hepatitis B viruses: stimulation by the upstream activating signal PS1 is orientation-dependent, distance-independent, and additive.Cross-packaging of human immunodeficiency virus type 1 vector RNA by spleen necrosis virus proteins: construction of a new generation of spleen necrosis virus-derived retroviral vectors.Involvement of long terminal repeat U3 sequences overlapping the transcription control region in human immunodeficiency virus type 1 mRNA 3' end formation.Distribution of mutations around rearranged heavy-chain antibody variable-region genes.The U3 region of Moloney murine leukemia virus contains position-independent cis-acting sequences involved in the nuclear export of full-length viral transcripts
P2860
Q24646050-E324725B-25FC-438D-9E92-69AB5E510359Q28284998-760E052A-3282-476A-A8B2-76B3E9FEF362Q33786060-0B7E3A71-C628-4777-902F-2AE00B6B15C7Q33811620-FFD793EC-18BF-4254-8E32-9D272EE037C1Q33835531-29F55306-6A2B-4FD4-98C9-2C5742740F89Q33856071-ED41AC74-7CDF-4BF6-9289-018ECF97B87EQ34200458-721F5C76-D068-4BD3-9606-C10FD0C62441Q34338573-1B2AE4FD-7E25-4110-8B94-FD70D108F8DBQ34452109-DC30F8ED-F94A-4AE8-AA0D-291A96824E2BQ34801348-7573F699-1AAE-4014-9320-E4D21EBE3BB5Q35034076-755E701E-F68A-404B-8498-7200B7C67FE7Q35224431-99009E47-5834-4299-A303-E648BBED4464Q35850215-8500F746-2774-4D96-8E94-EDF8BBE869FDQ35857779-793BE6BC-904E-42A0-9F54-C7BE7B3E82C8Q35890587-C3E7A29A-F2C5-43A5-82B5-609227F93E15Q36665437-6FE3B041-DAD6-4C84-858F-873A2EF1D5BAQ36682583-107E7772-9F0A-441D-95A4-77DB4B02D399Q36684169-2E8877A2-7948-4681-8B4F-09291A175E27Q36691325-63B34D13-FC1F-4027-9EBD-8F8772769B86Q36696130-B104878A-0C72-4452-9ABA-EA55DE46F9C1Q36713045-955866EC-5DA7-4217-AAAA-8C3F4A4197E9Q36789886-8F8422C6-0453-494A-8206-F16FE5766335Q36796409-F9369D7F-EDE7-4FF8-84F7-195C1470FAE9Q36801309-0A6978CE-3D5A-4C3D-A9D6-8D43039E06CEQ36829629-1F3FFD4A-0346-4F47-BAA7-A4480092D603Q36829664-6DD5F74B-9125-4254-B9A8-EC32AE656280Q36872014-9B05180A-2B0C-4B11-BA13-C5A108D084C9Q36918344-0F61EB19-21F3-40E4-837C-B6F91AB682F3Q39581352-F91F08D2-F4ED-40A8-BBF7-0F6767FAC350Q39596785-583F08AE-DA10-49E6-B701-73E49283023FQ39603431-60BE3F6B-CC54-48E7-9EAD-A5BBEB8AA19BQ39880686-82CF942A-D5CD-4EDE-B54A-29AAB98431C6Q39881108-0CE7DEEF-F2A4-4E3D-9FB4-09224A75EF2AQ40042280-DC0A61BC-A7F1-4C8C-A3CE-528C72870BCCQ40100616-75BECA59-B4F3-4157-BDE8-ACB2BFCCF105Q40508994-E7B8B186-50D2-49E8-AD6F-3B74C0EB3011Q40551545-787983FA-3D42-413F-B332-F96603DA37DCQ40677805-153CE4AC-BF6A-4C7C-ABF6-8B27A863F451Q41966971-C2A8A091-31D9-4F5E-AB52-68D36F8C635EQ42070127-52DA101F-C8A1-489F-B943-37C9944413EF
P2860
A promoterless retroviral vector indicates that there are sequences in U3 required for 3' RNA processing.
description
1987 nî lūn-bûn
@nan
1987 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի մարտին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
A promoterless retroviral vect ...... equired for 3' RNA processing.
@ast
A promoterless retroviral vect ...... equired for 3' RNA processing.
@en
A promoterless retroviral vect ...... equired for 3' RNA processing.
@nl
type
label
A promoterless retroviral vect ...... equired for 3' RNA processing.
@ast
A promoterless retroviral vect ...... equired for 3' RNA processing.
@en
A promoterless retroviral vect ...... equired for 3' RNA processing.
@nl
prefLabel
A promoterless retroviral vect ...... equired for 3' RNA processing.
@ast
A promoterless retroviral vect ...... equired for 3' RNA processing.
@en
A promoterless retroviral vect ...... equired for 3' RNA processing.
@nl
P2860
P356
P1476
A promoterless retroviral vect ...... equired for 3' RNA processing.
@en
P2093
J P Dougherty
P2860
P304
P356
10.1073/PNAS.84.5.1197
P407
P577
1987-03-01T00:00:00Z